Literature DB >> 1631287

Computed tomography of gynecologic neoplasms.

J W Walsh1.   

Abstract

Both CT and MR imaging have had a major impact on gynecologic oncologic imaging, and new technology and imaging techniques are still being introduced. CT maintains a role in gynecologic pelvic cancer imaging because of cost-effectiveness, high spatial resolution, fast examination time, and wide availability. CT is particularly advantageous for lymph node metastasis screening and guided-biopsy of metastases and recurrent tumor. CT currently is recommended for primary staging of ovarian cancer and advanced cancers of the cervix and endometrium, detection of persistent and metastatic gestational trophoblastic disease, and evaluation of recurrent gynecologic pelvic cancers.

Entities:  

Mesh:

Year:  1992        PMID: 1631287

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  6 in total

1.  Spiral CT of the female pelvis: clinical applications.

Authors:  B A Urban; E K Fishman
Journal:  Abdom Imaging       Date:  1995 Jan-Feb

Review 2.  CT and MRI of ovarian cancer.

Authors:  R Forstner; H Hricak; S White
Journal:  Abdom Imaging       Date:  1995 Jan-Feb

3.  Degenerated uterine fibroid mimicking hydrometra: fallacy in CT.

Authors:  Ch Tok; Si Bux; Si Mohamed; Bk Lim
Journal:  Biomed Imaging Interv J       Date:  2006-10-01

4.  Modeling and measurement of the variations of CT number distributions for mobile targets in cone-beam computed tomographic imaging.

Authors:  Imad Ali; Nesreen Alsbou; Salahuddin Ahmad
Journal:  J Appl Clin Med Phys       Date:  2015-01-08       Impact factor: 2.102

Review 5.  Imaging and cancer of the cervix in low- and middle-income countries.

Authors:  J Olpin; L Chuang; J Berek; D Gaffney
Journal:  Gynecol Oncol Rep       Date:  2018-07-20

6.  An incidentally found inflamed uterine myoma causing low abdominal pain, using Tc-99m-tektrotyd single photon emission computed tomography-CT hybrid imaging.

Authors:  Shahin Zandieh; Matthias Schütz; Reinhard Bernt; Jochen Zwerina; Joerg Haller
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.